dvm3602h
New vaccine protects against feline leukemia virus
The technological innovation is an expansion of the NOBIVAC NXT platform, and a breakthrough achievement against one of the ...
Merck Announces Expansion Of Nobivac NXT Platform For Treatment Of Feline Leukemia Virus
Merck Animal Health, a division of Merck & Co., Inc. (MRK), Tuesday announced the expansion of Nobivac NXT vaccine platform with the ...
Le Lézard9h
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribetm RNA Polymerase
TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribetm RNA Polymerase, a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA ...
Le Lézard9h
Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain
Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced the completion of enrollment of its U.S. Phase 3 ...
Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...